Correlation Between Fibroscan, Liver Biopsy, and Clinical Liver Function in Patients With Hepatitis C Virus Infection After Renal Transplantation

2009 ◽  
Vol 41 (6) ◽  
pp. 2425-2426 ◽  
Author(s):  
R. Muñoz ◽  
E. Ramírez ◽  
I. Fernandez ◽  
A. Martin ◽  
M. Romero ◽  
...  
2001 ◽  
Vol 38 (5) ◽  
pp. 919-934 ◽  
Author(s):  
Fabrizio Fabrizi ◽  
Paul Martin ◽  
Claudio Ponticelli

2015 ◽  
Vol 156 (21) ◽  
pp. 855-861 ◽  
Author(s):  
Alajos Pár ◽  
Áron Vincze ◽  
Gabriella Pár

Chronic hepatitis C virus infection associated with necroinflammation predisposes to liver fibrosis and cirrhosis, which lead to severe end-stage complications. Staging of fibrosis is of basic importance for the indication of antiviral treatment, for monitoring the response and predicting the prognosis of patients with hepatitis C virus related liver disease. Since liver biopsy, the “gold standard” diagnosis of fibrosis is invasive and it has some other limitations, non-invasive methods have been developed and widely used in the clinical practice. Serum biomarkers and physical approaches measuring liver stiffness by elastography as well as combination algorithms have been gradually been integrated into guidelines resulting in a reduction of the need for liver biopsy. The authors review these non-invasive fibrosis markers and discuss their role in the indication of treatment, follow-up, and assessment of prognosis of patients with chronic hepatitis C virus infection. Orv. Hetil., 2015, 156(21), 855–861.


2013 ◽  
Vol 61 (7) ◽  
pp. 1088-1096 ◽  
Author(s):  
María Guadalupe Sánchez-Parada ◽  
Bertha Adriana Alvarez-Rodríguez ◽  
Belinda Claudia Gómez-Meda ◽  
Rogelio Troyo-Sanromán ◽  
Laura Verónica Sánchez-Orozco ◽  
...  

2017 ◽  
Vol 48 (5) ◽  
pp. 337-344 ◽  
Author(s):  
Ryosuke Sugimoto ◽  
Motoh Iwasa ◽  
Nagisa Hara ◽  
Yasuyuki Tamai ◽  
Kyoko Yoshikawa ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document